170 related articles for article (PubMed ID: 12473987)
21. The prognostic value of postoperative serum immunoglobulin and complement component concentrations following gastric resection for carcinoma.
Janssen CW; Tønder O; Matre R
Acta Chir Scand; 1985; 151(1):63-7. PubMed ID: 3984658
[TBL] [Abstract][Full Text] [Related]
22. C1-INH and its effect on infarct size and ventricular function in an acute pig model of infarction, cardiopulmonary bypass, and reperfusion.
Schreiber C; Heimisch W; Schad H; Brkic A; Badiu C; Lange R; Bauernschmitt R
Thorac Cardiovasc Surg; 2006 Jun; 54(4):227-32. PubMed ID: 16755442
[TBL] [Abstract][Full Text] [Related]
23. C1-INH and C3/C4 levels do not correlate with long-term danazole dosage and HAE-1 attack-free interval.
Schneider LA; Maetzke J; Staib G; Scharffetter-Kochanek K
Allergy; 2005 Sep; 60(9):1214-5. PubMed ID: 16076313
[No Abstract] [Full Text] [Related]
24. Apotransferrin, C1-esterase inhibitor, and alpha 1-acid glycoprotein for cerebral protection during experimental hypothermic circulatory arrest.
Heikkinen J; Koskenkari J; Kaakinen T; Dahlbacka S; Kiviluoma K; Salomäki T; Laurila P; Hirvonen J; Biancari F; Parkkinen J; Juvonen T
Scand Cardiovasc J; 2004 Jun; 38(3):178-86. PubMed ID: 15223717
[TBL] [Abstract][Full Text] [Related]
25. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema.
Caliezi C; Wuillemin WA; Zeerleder S; Redondo M; Eisele B; Hack CE
Pharmacol Rev; 2000 Mar; 52(1):91-112. PubMed ID: 10699156
[TBL] [Abstract][Full Text] [Related]
26. Does angiotensin-converting enzyme inhibitor use exacerbate hereditary angioedema?
Hassen GW; Tu TJ; Wei DH; Hwang A; Lamothe R; Costea A; Liu LL; Smith T; Mualim F; Johnston P; Ng JM; Usmani S; Kalantari H
J Emerg Med; 2013 Oct; 45(4):602-8. PubMed ID: 23890533
[TBL] [Abstract][Full Text] [Related]
27. [C1-inhibitor plasma levels in neonates and mothers during labor].
Simonianová E; Tomásová H; Mydlilová A; Zoban P
Cesk Pediatr; 1993 Dec; 48(12):707-10. PubMed ID: 8137443
[TBL] [Abstract][Full Text] [Related]
28. Concentrations of serum proteins and erythrocyte sedimentation rate in patients with different histological types of gastric carcinoma.
Janssen CW; Maartmann-Moe H; Lie RT
Eur J Surg Oncol; 1987 Jun; 13(3):207-11. PubMed ID: 3595883
[TBL] [Abstract][Full Text] [Related]
29. [Determination of various fractions of complement (Cl, C3c, C3a, C4) in a population of healthy neonates].
Zito GA; Grano S; Gallo AB; Papaleo G; Tripodi V
Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1043-7. PubMed ID: 6982719
[TBL] [Abstract][Full Text] [Related]
30. Proteolytic inactivation of plasma C1- inhibitor in sepsis.
Nuijens JH; Eerenberg-Belmer AJ; Huijbregts CC; Schreuder WO; Felt-Bersma RJ; Abbink JJ; Thijs LG; Hack CE
J Clin Invest; 1989 Aug; 84(2):443-50. PubMed ID: 2668333
[TBL] [Abstract][Full Text] [Related]
31. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
Windfuhr JP; Alsenz J; Loos M
Mol Immunol; 2005 Apr; 42(6):657-63. PubMed ID: 15781109
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
33. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
Beyer-Enke SA; Strauss LG; Georgi M
Strahlenther Onkol; 1986 Jul; 162(7):441-7. PubMed ID: 3488595
[TBL] [Abstract][Full Text] [Related]
34. [Study of the relationship between complement activation and vascular endothelial damage in pregnancy induced hypertension].
Zheng Y; Chen Z; Yan J
Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):152-5. PubMed ID: 8758788
[TBL] [Abstract][Full Text] [Related]
35. Recombinant C1 inhibitor in brain ischemic injury.
Gesuete R; Storini C; Fantin A; Stravalaci M; Zanier ER; Orsini F; Vietsch H; Mannesse ML; Ziere B; Gobbi M; De Simoni MG
Ann Neurol; 2009 Sep; 66(3):332-42. PubMed ID: 19798727
[TBL] [Abstract][Full Text] [Related]
36. C1-esterase inhibitor in ischemia and reperfusion.
Horstick G
Immunobiology; 2002 Sep; 205(4-5):552-62. PubMed ID: 12396015
[TBL] [Abstract][Full Text] [Related]
37. C1-inhibitor protects against brain ischemia-reperfusion injury via inhibition of cell recruitment and inflammation.
Storini C; Rossi E; Marrella V; Distaso M; Veerhuis R; Vergani C; Bergamaschini L; De Simoni MG
Neurobiol Dis; 2005; 19(1-2):10-7. PubMed ID: 15837556
[TBL] [Abstract][Full Text] [Related]
38. Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease.
Kostner KM; Fahti RB; Case C; Hobson P; Tate J; Marwick TH
Clin Chim Acta; 2006 Mar; 365(1-2):129-34. PubMed ID: 16236275
[TBL] [Abstract][Full Text] [Related]
39. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement.
Fischer MB; Prodeus AP; Nicholson-Weller A; Ma M; Murrow J; Reid RR; Warren HB; Lage AL; Moore FD; Rosen FS; Carroll MC
J Immunol; 1997 Jul; 159(2):976-82. PubMed ID: 9218619
[TBL] [Abstract][Full Text] [Related]
40. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
Böhm I; Speck U; Schild H
Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
